270 related articles for article (PubMed ID: 15073029)
21. Primary Adrenal Insufficiency in a Boy with Type I Diabetes: The Importance of Considering X-linked Adrenoleukodystrophy.
Wiersma RE; Gupta AO; Lund TC; Sarafoglou K; Pierpont EI; Orchard PJ; Miller BS
J Endocr Soc; 2022 May; 6(5):bvac039. PubMed ID: 35450414
[TBL] [Abstract][Full Text] [Related]
22. Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.
Hegenbart U; Niederwieser D; Sandmaier BM; Maris MB; Shizuru JA; Greinix H; Cordonnier C; Rio B; Gratwohl A; Lange T; Al-Ali H; Storer B; Maloney D; McSweeney P; Chauncey T; Agura E; Bruno B; Maziarz RT; Petersen F; Storb R
J Clin Oncol; 2006 Jan; 24(3):444-53. PubMed ID: 16344316
[TBL] [Abstract][Full Text] [Related]
23. [X-linked adrenoleukodystrophy].
Aubourg P
Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
[TBL] [Abstract][Full Text] [Related]
24. Hematopoietic stem cell transplantation and hematopoietic stem cell gene therapy in X-linked adrenoleukodystrophy.
Cartier N; Aubourg P
Brain Pathol; 2010 Jul; 20(4):857-62. PubMed ID: 20626747
[TBL] [Abstract][Full Text] [Related]
25. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
[TBL] [Abstract][Full Text] [Related]
26. Brain-sparing cord blood transplantation for the borderline stage of adrenoleukodystrophy.
Yada Y; Torio M; Koga Y; Yamashita F; Ichimura T; Eguchi K; Ishimura M; Mushimoto Y; Hiwatashi A; Sasazuki M; Kira R; Sakai Y; Ohga S
Mol Genet Metab Rep; 2021 Sep; 28():100778. PubMed ID: 34221897
[TBL] [Abstract][Full Text] [Related]
27. Haematopoietic stem cell transplantation in 12 patients with cerebral X-linked adrenoleukodystrophy.
Baumann M; Korenke GC; Weddige-Diedrichs A; Wilichowski E; Hunneman DH; Wilken B; Brockmann K; Klingebiel T; Niethammer D; Kühl J; Ebell W; Hanefeld F
Eur J Pediatr; 2003 Jan; 162(1):6-14. PubMed ID: 12486501
[TBL] [Abstract][Full Text] [Related]
28. Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies.
Naik S; Martinez C; Leung K; Sasa G; Nguyen NY; Wu MF; Gottschalk S; Brenner M; Heslop H; Krance R
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1266-72. PubMed ID: 25765555
[TBL] [Abstract][Full Text] [Related]
29. Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Lee KH; Lee JH; Lee JH; Kim DY; Park HS; Choi EJ; Ko SH; Seol M; Lee YS; Kang YA; Jeon M; Baek S; Kang YL; Kim SH; Yun SC; Kim H; Jo JC; Choi Y; Joo YD; Lim SN
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1555-1566. PubMed ID: 28552421
[TBL] [Abstract][Full Text] [Related]
30. Therapy of X-linked adrenoleukodystrophy.
Semmler A; Köhler W; Jung HH; Weller M; Linnebank M
Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549
[TBL] [Abstract][Full Text] [Related]
31. Imaging in X-Linked Adrenoleukodystrophy.
van de Stadt SIW; Huffnagel IC; Turk BR; van der Knaap MS; Engelen M
Neuropediatrics; 2021 Aug; 52(4):252-260. PubMed ID: 34192790
[TBL] [Abstract][Full Text] [Related]
32. Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy.
Shapiro E; Krivit W; Lockman L; Jambaqué I; Peters C; Cowan M; Harris R; Blanche S; Bordigoni P; Loes D; Ziegler R; Crittenden M; Ris D; Berg B; Cox C; Moser H; Fischer A; Aubourg P
Lancet; 2000 Aug; 356(9231):713-8. PubMed ID: 11085690
[TBL] [Abstract][Full Text] [Related]
33. Non-myeloablative conditioning for second hematopoietic cell transplantation for graft failure in patients with non-malignant disorders: a prospective study and review of the literature.
Mallhi K; Orchard PJ; Miller WP; Cao Q; Tolar J; Lund TC
Bone Marrow Transplant; 2017 May; 52(5):726-732. PubMed ID: 28092353
[TBL] [Abstract][Full Text] [Related]
34. The experience of allogeneic hematopoietic stem cell transplantation in a patient with X-linked adrenoleukodystrophy.
Ciftciler R; Goker H; Buyukasık Y; Topcu M; Gevher N; Demiroglu H
Transfus Apher Sci; 2020 Feb; 59(1):102583. PubMed ID: 31350055
[TBL] [Abstract][Full Text] [Related]
35. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
36. Childhood Cerebral Adrenoleukodystrophy: MR Perfusion Measurements and Their Use in Predicting Clinical Outcome after Hematopoietic Stem Cell Transplantation.
McKinney AM; Benson JC; Nascene DR; Eisengart J; Salmela MB; Loes DJ; Zhang L; Patel K; Raymond GV; Miller WP
AJNR Am J Neuroradiol; 2016 Sep; 37(9):1713-20. PubMed ID: 27079370
[TBL] [Abstract][Full Text] [Related]
37. The Changing Face of Adrenoleukodystrophy.
Zhu J; Eichler F; Biffi A; Duncan CN; Williams DA; Majzoub JA
Endocr Rev; 2020 Aug; 41(4):577-93. PubMed ID: 32364223
[TBL] [Abstract][Full Text] [Related]
38. Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease Prophylaxis.
Castagna L; Mussetti A; Devillier R; Dominietto A; Marcatti M; Milone G; Maura F; de Philippis C; Bruno B; Furst S; Blaise D; Corradini P; Montefusco V
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1549-1554. PubMed ID: 28499937
[TBL] [Abstract][Full Text] [Related]
39. Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimen.
Resnick IB; Abdul Hai A; Shapira MY; Bitan M; Hershkovitz E; Schwartz A; Ben-Harush M; Or R; Slavin S; Kapelushnik J
Clin Transplant; 2005 Dec; 19(6):840-7. PubMed ID: 16313334
[TBL] [Abstract][Full Text] [Related]
40. Unrelated donor transplantation after reduced intensity conditioning as an approach for patients lacking related donors for allogeneic stem cell transplantation.
Hoepfner S; Goerner M; Benner A; Henning P; Ho AD
J Hematother Stem Cell Res; 2003 Jun; 12(3):331-9. PubMed ID: 12857374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
